Presilium Private Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$721K Sell
4,603
-2
-0% -$300 0.11% 48
2026
Q1
$703K Buy
+4,605
New +$706K 0.12% 42

Other funds holding NVS

Presilium Private Wealth's NVS Position: Q2 2026 in Review

Presilium Private Wealth reduced its Novartis (NVS) stake by 0.04% in Q2 2026, selling an estimated $300 and leaving 4,603 shares worth $721K. The position accounts for 0.11% of the portfolio, ranked #48.

Presilium Private Wealth first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. 1,610 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Presilium Private Wealth held 4,603 shares of Novartis worth $721K as of Q2 2026.
  • Presilium Private Wealth sold 2 Novartis shares in Q2 2026, an estimated $300.
  • Novartis made up 0.11% of Presilium Private Wealth's portfolio in Q2 2026, its #48 holding.
  • Presilium Private Wealth first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
  • 1,610 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Presilium Private Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.